Jim Simons Clearside Biomedical, Inc. Call Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLSD
# of Institutions
56Shares Held
15.1MCall Options Held
22.7KPut Options Held
200-
Armistice Capital, LLC New York, NY3.96MShares$5.14 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$3.24 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.86 Million3.43% of portfolio
-
Carmignac Gestion Paris, I02.13MShares$2.77 Million0.05% of portfolio
-
Black Rock Inc. New York, NY758KShares$985,6930.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $78.2M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...